Ionis Pharmaceuticals Inc (NASDAQ:IONS)

62.71
Delayed Data
As of Sep 20
 -0.23 / -0.37%
Today’s Change
43.27
Today|||52-Week Range
86.58
+16.00%
Year-to-Date

Today’s Trading

Previous close62.94
Today’s open62.98
Day’s range62.00 - 63.45
Volume1,600,778
Average volume (3 months)1,180,793
Market cap$9.3B
Data as of 4:00pm ET, 09/20/2019

Growth & Valuation

Earnings growth (last year)+2,515.50%
Earnings growth (this year)-107.97%
Earnings growth (next 5 years)+49.00%
Revenue growth (last year)+18.12%
P/E ratio21.0
Price/Sales12.09
Price/Book8.71

Competitors

 Today’s
change
Today’s
% change
GLPGGalapagos NV+2.15+1.35%
SAGESAGE Therapeutics In...+1.73+1.06%
BHCValeant Pharmaceutic...-0.29-1.25%
ALNYAlnylam Pharmaceutic...+1.90+2.25%
Data as of 6:30pm ET, 09/20/2019

Financials

Next reporting dateNovember 4, 2019
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$599.7M
Annual profit (last year)$276.9M
Net profit margin46.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Stanley T. Crooke
Chief Operating Officer &
Director
Brett P. Monia
Corporate headquarters
Carlsbad, California

Forecasts